Technical Support: menoci@medizin.uni-goettingen.de
Department of Medical Informatics
University Medical Center Göttingen
Imprint
View primary antibody
Basic data
| PID | primary-0179 |
| EPIC PID | https://hdl.handle.net/21.11124/primary-0179 |
| Research group | RG Moser |
| Quality (mean) | no score (0.00) |
| Sharing level | Public |
Antibody data
| Antigen symbol | TUBA4A |
| Antibody Registry ID(s) | AB_887862 |
| Name | Anti-alpha-Tubulin antibody |
| Alternative name | |
| Lab ID | |
| Tag / Fluorophore | |
| Raised in | Mouse |
| Reacts with | Human, Rat, Mouse, Vertebrates, invertebrates, Yeast |
| Clone | 3A2 |
| Isotype | IgG |
| Clonality | monoclonal |
| Demasking | unknown |
| Antigen | Synthetic peptide corresponding to AA 419 to 435 from human α-tubulin 4A |
| Crafted By | company |
| Company / Manufacturer | Synaptic Systems |
| Catalog no. | 302 211 |
| Lot no. | |
| Description | WB: 1 : 1000 up to 1 : 5000 (AP staining) IP: yes ICC: 1 : 500 up to 1 : 1000 IHC: 1 : 500 IHC-P/FFPE: 1 : 500 up to 1 : 1000 ELISA: yes |
| Localization | |
| Storage instruction | For reconstitution add 100 µl H2O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C until use. |
| Receipt date | 2021-01-01 00:00:00 |
| Preparation date | 2021-03-09 00:00:00 |
| Created by | Klauenberg, Vanessa |
| Last modified | Klauenberg, Vanessa |
External links
| Antibodypedia | - |
| HGNC | http://www.genenames.org/cgi-bin/gene_symbol_report?match=TUBA4A |
| Wikipedia | http://en.wikipedia.org/wiki/TUBA4A |
| Uniprot | http://www.uniprot.org/uniprot/?query=TUBA4A |
| GeneCards | http://www.genecards.org/cgi-bin/carddisp.pl?gene=TUBA4A |
| Antibody Registry | http://antibodyregistry.org/search?q=AB_887862 |
Applications
No application comments yet.
Linked publications
Circumvention of common labeling artifacts using secondary nanobodies
Sograte-Idrissi S, Schlichthaerle T, Duque-Afonso CJ, Alevra M, Strauss S, Moser T, Jungmann R, Rizzoli S, Opazo F
bioRxiv 2019 : 10.1101/818351
Circumvention of common labelling artefacts using secondary nanobodies
Sograte-Idrissi S, Schlichthaerle T, Duque-Afonso CJ, Alevra M, Strauss S, Moser T, Jungmann R, Rizzoli SO, Opazo F
Nanoscale 2020 : 10.1039/d0nr00227e
